Praluzatamab

Tax included
Praluzatamab is a monoclonal antibody targeting the activated leukocyte cell adhesion molecule (ALCAM/CD116). Praluzatamab can be used to synthesize Praluzatamab ravtansine (antibody-drug conjugates). Praluzatamab can be used for research of cancers.
MedChemExpress 
HY-P99788

Data sheet

Size
Multiple sizes
Reactivity
ADC Antibody; ALCAM/CD166
Application
Cancer-programmed cell death
CAS
2145109-70-0